Defence Therapeutics refines ADC strategy with advisory board input
Go back to Defence Therapeutics refines ADC strategy with advisory board input| (AMEX: DTCFF) | Delayed: 0.33 -0.01 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.34 | 52 Week High | $ | |||
| Open | $0.33 | 52 Week Low | $ | |||
| Day High | $0.33 | P/E | N/A | |||
| Day Low | $0.33 | EPS | $ | |||
| Volume | 1,000 | |||||
